Cargando…

Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer

Neoadjuvant chemotherapy (NACT) is used in locally advanced breast cancer to reduce tumour burden prior to surgical resection. However, only a subset of NACT treated patients will respond to treatment or achieve a pathologic complete response (pCR). This multicenter, prospective study (CTRIAL-IE (IC...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGuire, Andrew, Casey, Maire-Caitlin, Waldron, Ronan M., Heneghan, Helen, Kalinina, Olga, Holian, Emma, McDermott, Ailbhe, Lowery, Aoife J., Newell, John, Dwyer, Róisín M., Miller, Nicola, Keane, Maccon, Brown, James A.L., Kerin, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408914/ https://www.ncbi.nlm.nih.gov/pubmed/32645898 http://dx.doi.org/10.3390/cancers12071820

Ejemplares similares

Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G., et al.
Publicado: (2022)

Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G, et al.
Publicado: (2022)

Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
por: Davey, Matthew G., et al.
Publicado: (2023)

Relationship between Circulating and Tissue microRNAs in a Murine Model of Breast Cancer
por: Waters, Peadar S., et al.
Publicado: (2012)

Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab
por: McGuire, Andrew, et al.
Publicado: (2017)

Identification and Validation of miRNAs as Endogenous Controls for RQ-PCR in Blood Specimens for Breast Cancer Studies
por: McDermott, Ailbhe M., et al.
Publicado: (2013)

Dysregulated miR-183 inhibits migration in breast cancer cells
por: Lowery, Aoife J, et al.
Publicado: (2010)

Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study
por: Davey, Matthew G., et al.
Publicado: (2021)

Impact of receptor phenotype on nodal burden in patients with breast cancer who have undergone neoadjuvant chemotherapy
por: Boland, M. R., et al.
Publicado: (2017)

Oncological Risk in Autologous Stem Cell Donation for Novel Tissue-Engineering Approaches to Postmastectomy Breast Regeneration
por: O’Halloran, Niamh, et al.
Publicado: (2019)

MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors
por: Richard, Vinitha, et al.
Publicado: (2021)

Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer
por: Casey, M.C., et al.
Publicado: (2019)

Quantifying Tip60 (Kat5) stratifies breast cancer
por: McGuire, A., et al.
Publicado: (2019)

Exploring circulating micro‐RNA in the neoadjuvant treatment of breast cancer
por: Casey, Máire‐Caitlín, et al.
Publicado: (2016)

Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy
por: Walsh, Elaine M., et al.
Publicado: (2018)

Preoperative Breast Magnetic Resonance Imaging as a Predictor of Response to Neoadjuvant Chemotherapy
por: Browne, Robert, et al.
Publicado: (2022)

Investigating the Potential and Pitfalls of EV-Encapsulated MicroRNAs as Circulating Biomarkers of Breast Cancer
por: Moloney, Brian M., et al.
Publicado: (2020)

Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer
por: Davoren, Pamela A, et al.
Publicado: (2008)

A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score©
por: Davey, Matthew G., et al.
Publicado: (2022)

MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer
por: Davey, Matthew G., et al.
Publicado: (2022)

A radiomic model to classify response to neoadjuvant chemotherapy in breast cancer
por: McAnena, Peter, et al.
Publicado: (2022)

Assessing awareness of colorectal cancer symptoms and screening in a peripheral colorectal surgical unit: a survey based study
por: McVeigh, Terri P, et al.
Publicado: (2013)

Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer
por: McDermott, Ailbhe M., et al.
Publicado: (2014)

Uncharted waters: rare and unclassified cardiomyopathies characterized on cardiac magnetic resonance imaging
por: O’Neill, Ailbhe C., et al.
Publicado: (2010)

Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles
por: Chabria, Yashna, et al.
Publicado: (2021)

The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre
por: McVeigh, Terri Patricia, et al.
Publicado: (2014)

MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid
por: Khan, Sonja, et al.
Publicado: (2015)

MicroRNAs as Novel Biomarkers for Breast Cancer
por: Heneghan, H. M., et al.
Publicado: (2010)

Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort
por: Jalali, Amirhossein, et al.
Publicado: (2022)

Impact of Tumour Epithelial Subtype on Circulating microRNAs in Breast Cancer Patients
por: Waters, Peadar S., et al.
Publicado: (2014)

Overview of MicroRNA Expression in Predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A Systematic Review
por: Davey, Matthew G, et al.
Publicado: (2022)

Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

The Sodium Iodide Symporter (NIS) and Potential Regulators in Normal, Benign and Malignant Human Breast Tissue
por: Ryan, James, et al.
Publicado: (2011)

Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring
por: McGuire, Andrew, et al.
Publicado: (2015)

The Impact of Preoperative Breast Magnetic Resonance Imaging on Surgical Management in Symptomatic Patients With Invasive Lobular Carcinoma
por: Moloney, Brian M, et al.
Publicado: (2020)

Evolution of a research field—a micro (RNA) example
por: Casey, Máire-Caitlín, et al.
Publicado: (2015)

MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer
por: Lowery, Aoife J, et al.
Publicado: (2009)

Adipose-Derived Stem Cells in Novel Approaches to Breast Reconstruction: Their Suitability for Tissue Engineering and Oncological Safety
por: O’Halloran, Niamh, et al.
Publicado: (2017)

MicroRNA Expression Profiles and Breast Cancer Chemotherapy
por: Davey, Matthew G., et al.
Publicado: (2021)

Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways
por: Garrido, Pablo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f990g7i8pifhbtnijigsln3uso